HLN
Haleon plc
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · GB
$9.60
−2.64%Forward multiples
Based on analyst estimates
- P/E forward
- 10.33x
- P/E 2026E
- 16.79x
- P/E 2027E
- 15.42x
- P/E 2028E
- 14.20x
- P/S forward
- 1.46x
Trailing multiples
Trailing twelve months
- P/E TTM
- 11.28x
- PEG TTM
- 1.22x
- Price / book
- 1.92x
- Price / sales
- 1.61x
- Price / cash flow
- 13.66x
Enterprise value
- Enterprise value
- $52.3B
- EV / sales
- 1.99x
- EV / EBITDA
- 7.72x
- EV / EBIT
- 8.78x
- Market cap
- $42.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026